While systemic corticosteroids (SCS) are frequently used to treat atopic dermatitis (AD), there are few studies that have examined the safety and efficacy of this practice. A recent review studied the available evidence to summarize the available evidence for using SCSs in AD. Currently, AAD guidelines for treating AD recommend systemic therapy for persistent, moderate-to-severe …
The FDA relies on consumers to report adverse events associated with product use to assist them in regulating product safety. A recent study looked into the consumer adverse event reports that were submitted to the FDA that had to do with cosmetics and personal care products (PCP) that are marketed for pediatric use. One objective …
Terbinafine is an effective systemic treatment for onychomycosis, a fungal infection of the nail. Pediatric cases of the infection, which results in discoloration and thickening of the nails, usually respond well to topical treatments, but when the infection starts to affect the nail’s matrix, a systemic option is needed. When adults use terbinafine, they undergo …
Consent for procedures and understanding treatment options takes on some nuance when working with a pediatric population. Informed consent was designed with the guiding principle that patients should be able to make their own decisions regarding their medical care. But what happens when a patient is a child and may lack the autonomy to decide …
Keloids are thought to be rare in children as they are most commonly seen in the second decade of life. This is thought to be due to the pathogenesis of the disorder brought on by hormonal changes in people in young adult hood. A recent study examined the demographic characteristics of non-burn-related keloids in children …